 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Chicago, IL USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Durham, NC USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Charlottesville, VA USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Cleveland, OH USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Cleveland, OH USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Hackensack, NJ USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Chicago, IL USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Boston, MA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
New Haven, CT USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Buffalo, NY USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Salt Lake City, UT USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Evanston, IL USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Palo Alto, CA USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
New York, NY USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Philadelphia, PA USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Houston, TX USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Seattle, WA USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
New York, NY USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Jacksonville, FL USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
San Francisco, CA USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Saginaw, MI USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Gainsville, FL USA |
|
05/09/2008 |
|
|
|
Details |
|
A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
|
San Antonio, TX USA |
|
05/09/2008 |
|
|
|
|
|
Details |
|
A Phase II Study of Bevacizumab (Avastin) Plus Temodar and Tarceva After Radiation Therapy and Temodar in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Who Are Stable Following Radiation |
|
San Francisco, CA USA |
|
04/27/2008 |
|
|
|
Details |
|
Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme |
|
Houston , TX |
|
04/27/2008 |
|
|
|
|
|
Details |
|
A Phase II Trial of Concurrent Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib in the First-Line Treatment of Patients With Glioblastoma Multiforme |
|
Fort Myers, FL USA |
|
04/27/2008 |
|
|
|
Details |
|
Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme |
|
Durham, NC USA |
|
04/27/2008 |
|
|
|
|
|
Details |
|
Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme |
|
Charlottesville, VA USA |
|
04/27/2008 |
|
|
|
Details |
|
Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme |
|
New York, NY USA |
|
04/27/2008 |
|
|
|
|
|
Details |
|
Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme |
|
Boston, MA USA |
|
04/27/2008 |
|
|
|
Details |
|
A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme
|
|
Houston, TX USA |
|
04/16/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of Temozolomide and Intrathecal DepoCyt in Patients with Neoplastic Meningitis
|
|
Houston, TX USA |
|
04/16/2008 |
|
|
|
Details |
|
A Phase II Study of Rituximab and Temozolomide in Recurrent Primary CNS Lymphoma
|
|
Houston, TX USA |
|
04/16/2008 |
|
|
|
|
|
Details |
|
Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma |
|
Houston, TX USA |
|
04/15/2008 |
|
|
|
Details |
|
Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
|
|
Houston, TX USA |
|
04/15/2008 |
|
|
|
Details |
|
A Phase I Dose-Finding and Pharmacokinetic Study of Intravenous RTA 744 Injection in Patients with Recurrent or Refractory Glioma, with or without Concurrent Treatment with Enzyme-Inducing Anticonvulsant Drug Therapy.
|
|
Houston, TX USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
New York, NY USA |
|
04/15/2008 |
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Durham, NC USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Houston, TX USA |
|
04/15/2008 |
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Los Angeles, CA USA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Bethesda, MD USA |
|
04/15/2008 |
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Boston, MA |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Tampa, FL USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Houston, TX USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Akron, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Cleveland, OH |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Springfield, MO USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Goldsboro, NC USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Greenville, SC USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Akron, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Wynnewood, PA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Kingsport, TN USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Newark, DE USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Philadelphia, PA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Mobile, AL USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Loma Linda, CA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Sacramento, CA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Pomona, CA USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Sacramento, CA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Lewes, DE USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Newark, DE USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Jacksonville, FL USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, GA USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Honolula, HI USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Boise, ID USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Maywood, IL USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Harvey, IL USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Chicago, IL USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
South Bend,, IN USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
South Bend, IN USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Annapolis, MD USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Detroit, MI USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Royal Oak, MI USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Saint Louis Park, MN USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Edina, MN USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Robbinsdale, MN USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Minneapolis, MN USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Cape Girardeau, MO USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Kansas City, MO USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Saint Louis, MO USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
St Louis, MO USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Joplin, MO USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Omaha, NE USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Concord, NH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Lebanon, NH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Voorhees, NJ USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Marlton, NJ USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Toms River, NJ USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Long Branch,, NJ USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Syracuse, NY USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Rochester, NY USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Minot, ND USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Chillicothe, OH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Akron, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Canton, OH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Wooster, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, OH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Zanesville, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, OH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Tulsa, OK USA |
|
04/11/2008 |
|
|
|
|
|
